The trajectory of Viagra, formerly marketed by copyright, presents a intricate case study for stakeholders considering the pharmaceutical arena . While its initial success and creation of billions in revenue , the exclusivity lapse has opened the door for generic medications, significantly diminishing profit potential . This shift raises concerns a